课题基金 / 基金详情

Analysis of a Novel Secreted Protein in Neuroblastoma

Analysis of a Novel Secreted Protein in Neuroblastoma
神经母细胞瘤中新型分泌蛋白的分析
批准号:
7140105
负责人:
JIANHUA YANG
金额:
$12.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-13 至 2007-08-31

项目摘要

项目成果

JIANHUA YANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neuroblastoma is the most common extracranial solid tumor in children and is responsible for 15% of pediatric cancer deaths. Metastatic spread of disease is the principal factor associated with poor outcome. These tumors derive from embryonic neural crest cells. Aberrant responses to neural crest growth and differentiation signals are thought to play an important role in determining the malignant phenotype of neuroblastoma tumor cells, however, the molecular mechanisms regulating the proliferation and metastasis of this tumor remain largely unknown. Growth factors, cytokines and chemokines play important roles in tumor proliferation, invasion, and metastasis of neuroblastoma. We cloned a novel secreted molecule, named Neuroblastoma Derived Secreted Protein (NDSP), from our microarray-based analysis of differential gene expression in high risk neuroblastoma tumors. Our preliminary studies have shown that NDSP is highly expressed in neuroblastoma cells, displays a minimal expression profile in normal human tissues, and its encoded protein is secreted into culture media. In addition, we found that NDSP is a Nerve Growth Factor (NGF) responsive gene in neuroblastoma cells. The central hypothesis of this work is that NDSP is a novel diagnostic marker for neuroblastoma and essential for neuroblastoma growth and metastasis. The proposed experiments will test this hypothesis by analyzing the expression pattern and biological role of NDSP in neuroblastoma. The specific aims of this application are: 1) to determine whether NDSP is a potential biomarker for neuroblastoma; 2) to determine whether NDSP is involved in regulating neuroblastoma tumor formation and dissemination. It is likely that NDSP is not only a potential drug target for therapeutic intervention but also a potential diagnostic biomarker.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cellsig.2010.05.007
发表时间: 2010-12
期刊: Cellular signalling
影响因子: 4.8
作者: [Sun W, Yang J]
通讯作者: Yang J
USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation.
USP4靶向TAK1以下调TNFα诱导的NF-κB激活。
DOI: 10.1038/cdd.2011.11
发表时间: 2011-10
期刊: Cell death and differentiation
影响因子: 12.4
作者: []
通讯作者:
DOI: 10.1016/j.cellsig.2010.09.006
发表时间: 2011-01
期刊: Cellular signalling
影响因子: 4.8
作者: [Mao R, Fan Y, Mou Y, Zhang H, Fu S, Yang J]
通讯作者: Yang J
Phosphorylation of Thr-516 and Ser-520 in the kinase activation loop of MEKK3 is required for lysophosphatidic acid-mediated optimal IkappaB kinase beta (IKKbeta)/nuclear factor-kappaB (NF-kappaB) activation.
MEKK3 激酶激活环中 Thr-516 和 Ser-520 的磷酸化是溶血磷脂酸介导的最佳 IkappaB 激酶 β (IKKbeta)/核因子-kappaB (NF-kappaB) 激活所必需的。
DOI: 10.1074/jbc.m109.051219
发表时间: 2010
期刊: The Journal of biological chemistry
影响因子: --
作者: [Sun,Wenjing, Ge,Ningling, Yu,Yang, Burlingame,Susan, Li,Xiaonan, Zhang,Ming, Ye,Shenglong, Fu,Songbin, Yang,Jianhua]
通讯作者: Yang,Jianhua
6
    CAMKV Kinase Signaling in Neuroblastoma
    • 批准号:
      10239070
    • 项目类别:
    • 资助金额:
      $45.34万
    • 财政年份:
      2020
    • 负责人:
      JIANHUA YANG
    • 依托单位:
    CAMKV Kinase Signaling in Neuroblastoma
    • 批准号:
      10630951
    • 项目类别:
    • 资助金额:
      $43.73万
    • 财政年份:
      2020
    • 负责人:
      JIANHUA YANG
    • 依托单位:
    CAMKV Kinase Signaling in Neuroblastoma
    • 批准号:
      10752785
    • 项目类别:
    • 资助金额:
      $44.68万
    • 财政年份:
      2020
    • 负责人:
      JIANHUA YANG
    • 依托单位:
    CAMKV Kinase Signaling in Neuroblastoma
    • 批准号:
      10035064
    • 项目类别:
    • 资助金额:
      $47.6万
    • 财政年份:
      2020
    • 负责人:
      JIANHUA YANG
    • 依托单位:
    海外基金